B cell complement receptor 2 transfer reaction

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3671-3678

  Lindorfer, Margaret A ^a   Jinivizian, Hasmig B ^a   Foley, Patricia L ^a   Kennedy, Adam D ^a   Solga, Michael D ^a   Taylor, Ronald P ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL COMPLEMENT RECEPTOR 2; B LYMPHOCYTE RECEPTOR; E C RECEPTOR 1; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; COMPLEMENT SYSTEM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; OPSONIZATION; PRIORITY JOURNAL;

EID: 0037378048     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3671     Document Type: Article

References (51)

1. Pepys, M. B. 1972. Role of complement in induction of the allergic response. Nat. New Biol. 237:157.
2. Carroll, M. C. 2000. The role of complement in B cell activation and tolerance. Adv. Immunol. 74:61.
3. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393.
4. Heyman, B. 2000. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18:709.
5. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3δ of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
6. Tew, J. G., J. Wu, D. Qin, S. Helm, G. F. Burton, and A. K. Szakal. 1997. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol. Rev. 156:39.
7. Qin, D., J. Wu, M. C. Carroll, G. F. Burton, A. K. Szakal, and J. G. Tew. 1998. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161:4549.
8. Tolnay, M., and G. C. Tsokos. 1998. Complement receptor 2 in the regulation of the immune response. Clin. Immunol. Immunopathol. 88:123.
9. Boackle, S. A., M. A. Morris, V. M. Holers, and D. R. Karp. 1998. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J. Immunol. 161:6537.
10. Chen, Z., S. Koralov, and G. Kelsoe. 2000. Regulation of humoral immune responses by CD21/CD35. Immunol. Rev. 176:194.
11. Cherukuri, A., P. C. Cheng, H. W. Sohn, and S. K. Pierce. 2001. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14:169.
12. Lindorfer, M. A., C. S. Hahn, P. L. Foley, and R. P. Taylor. 2001. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol. Rev. 183:10.
13. Craig, M. L., A. J. Bankovich, J. McElhenney, and R. P. Taylor. 2000. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum. 43:2265.
14. Reinagel, M. L., and R. P. Taylor. 2000. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages. J. Immunol. 164:1977.
15. Ahearn, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
16. r membrane protein as the C3δ receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81:881.
17. Currie, M. S., M. Vala, D. S. Pisetsky, C. S. Greenburg, J. Crawford, and H. J. Cohen. 1990. Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood 75:1699.
18. Ross, G. D., W. J. Yount, M. J. Walport, J. B. Winfield, C. J. Parker, C. R. Fuller, R. P. Taylor, B. L. Myones, and P. J. Lachmann. 1985. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135:2005.
19. Jakubik, J. J., M. Saifuddin, D. M. Takefman, and G. T. Spear. 2000. Immune complexes containing human immunodeficiency virus type I primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes. J. Virol. 74:552.
20. Benedetto, A., A. Di Caro, M. P. Camporiondo, D. Gallone, S. Zaniratti, V. Tozzi, and G. Elia. 1992. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers. Clin. Immunol. Immunopathol. 62:139.
21. Moir, S., A. Malaspina, Y. Li, T. W. Chun, T. Lowe, J. Adelsberger, M. Baseler, L. A. Ehler, S. Liu, R. T. Davey, et al. 2000. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 192:637.
22. Frémeaux-Bacchi, V., J. P. Kolb, S. Rakotobé, M. D. Kazatchkine, and E. M. Fischer. 1999. Functional properties of soluble CD21. Immunopharmacology 42:31.
23. Huemer, H. P., C. Larcher, W. M. Prodinger, A. L. Petzer, M. Mitterer, and N. Falser. 1993. Determination of soluble CD21 as a parameter of B cell activation. Clin. Exp. Immunol. 93:195.
24. Fremeaux-Bacchi, V., I. Bernard, F. Maillet, J. Mani, M. Fontaine, J. Bonnefoy, M. D. Kazatchkine, and E. Fischer. 1996. Human lymphocytes shed a soluble form of CD21 (the C3δγ/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23. Eur. J. Immunol. 26:1497.
25. Boackle, S. A., J. M. Brown, and V. M. Holers. 2000. Role of complement receptors type 1 (CR1/CD21) in murine SLE. Immunopharmacology 49:29.
26. Takahashi, K., Y. Kozono, T. J. Waldschmidt, D. Berthiaume, R. J. Quigg, A. Baron, and V. M. Holers. 1997. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2:CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159:1557.
27. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224.
28. Hemmi, H., and T. R. Bremell. 1985. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin. Jpn. J. Cancer Res. 76:345.
29. Tedder, T. F., L. T. Clement, and M. D. Cooper. 1984. Expression of C38 receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:678.
30. Taylor, R. P., W. M. Sutherland, E. N. Martin, P. J. Ferguson, M. L. Reinagel, E. Gilbert, K. Lopez, N. L. Incardona, and H. D. Ochs. 1997. Bispecific monoclonal antibody complexes bound to primate erythrocyte CR1 facilitate virus clearance in a monkey model. J. Immunol. 158:842.
31. Ilag, L. L., N. H. Olson, T. Dokland, C. L. Music, R. H. Chenz, Z. Bowen, R. McKenna, M. G. Rossmann, T. S. Baker, and N. L. Incardona. 1995. DNA packaging intermediates of bacteriophage ΦX174. Structure 3:353.
32. Tosic, L., W. M. Sutherland, J. Kurek, J. C. Edberg, and R. P. Taylor. 1989. Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-Sepharose. J. Immunol. Methods 120:241.
33. O'Shea, J. J., E. J. Brown, B. E. Seligmann, J. A. Metcalf, M. M. Frank, and J. I. Gallin. 1985. Evidence for the distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580.
34. Prodinger, W. M., M. G. Schwendinger J. Schoch, M. Kochle, C. Larcher, and M. P. Dierich. 1998. Characterization of C3δγ binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). J. Immunol. 161:4604.
35. Taylor, R. P., E. N. Martin, M. L. Reinagel, A. Nardin, M. Craig, Q. Choice, R. Schlimgen, S. Greenbaum, N. L. Incardona, and H. D. Ochs. 1997. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model. J. Immunol. 159:4035.
36. Sasaki, T., J. Sasaki-Irie, and J. M. Penninger. 2001. New insights into the transmembrane protein tyrosine phosphatase CD45. Int. J. Biochem. Cell Biol. 33:1041.
37. Craig, M. L., A. J. Bankovich, and R. P. Taylor. 2002. Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages. Clin. Immunol. 105:36.
38. Chen, A., P. Engel, and T. F. Tedder. 1995. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J. Exp. Med. 183:519.
39. Guthridge, J. M., K. Young, M. G. Gipson, M. R. Sarrias, G. Szakonyi, X. S. Chen, A. Malaspina, E. Donbghue, J. A. James, J. D. Lambris, et al. 2001. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3δ interface. J. Immunol. 167:5758.
40. Humphrey, J. H., and M. M. Frank. 1967. The localization of non-microbial antigens in the draining lymph nodes of tolerant normal and primed rabbits. Immunology 13:87.
41. Brown, J. C., E. J. Holborow, G. Harris, M. Papamicha, and V. Sljivic. 1973. The localization of aggregated human γ-globulin in the spleens of normal mice. Immunology 24:955.
42. Papamichail, M., C. Gutierrez, P. Embling, P. Johnson, E. J. Holborow, and M. B. Pepys. 1975. Complement dependence of localization of aggregated IgG in germinal centers. Scand. J. Immunol. 4:343.
43. Klaus, G. G. B. 1978. The generation of memory cells. Immunology 34:643.
44. Humphrey, J. H., D. Grennan, and V. Sundaram. 1984. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur. J. Immunol. 14:859.
45. Heinen, E., L. Simar, M. Braun, P. G. Coulie, J. Van Snick, M. Moeremans, N. Cormann, and C. Kinet-Denoel. 1986. Transfer of immune complexes from lymphocytes to follicular dendritic cells. Eur. J. Immunol. 16:167.
46. Van der Berg, T. K., E. A. Dopp, M. R. Daha, G. Kraal, and C. D. Dijkstra. 1992. Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur. J. Immunol. 22:957.
47. Kacani, L., W. M. Prodinger, G. M. Sprinzl, M. G. Schwendinger, M. Spruth, H. Stoiber, S. Döpper, S. Steinhuber, F. Steindl, and M. P. Dierich. 2000. Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2. J. Virol. 74:7997.
48. Liu, Y., J. Xu, O. de Bouteiller, C. L. Parham, G. Grouard, O. Djossou, B. de Saint-Vis, S. Lebecque, J. Banchereau, and K. W. Moore. 1997. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185:165.
49. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type I receptor. Int. Immunol. 2:651.
50. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
51. Holers, M. V. 2000. Phenotypes of complement knockouts. Immunopharmacology 49:125.